| |
|
|
|
|
| Session I - Development of the Pulmonary Immune
System: Who are the players and what do they do in the
lung? |
Chair:
Michael Sherman, M.D. |
|
|
| Immune system tissue in the lung |
|
| 8:30-8:55 |
Speaker: Michael Sherman, M.D. |
Pulmonary Immune Cells Go to School
Lesson 1. Learning form
Lactoferrin |
| 8:55-9:05 |
Discussant: Michael Frank, M.D. |
|
| 9:05-9:10 |
Discussant: Dallas Hyde, Ph.D. |
|
| 9:15-9:45 |
DISCUSSION |
|
|
|
| Ontogeny of immune system in Lung |
|
| 9:45-10:10 |
Speaker: David Lewis, M.D. |
Developmental Mechanisms that May Limit or
Alter Pulmonary T Cell Responses |
| 10:10-10:20 |
Discussant: Joseph Bellanti, M.D. |
|
| 10:20-10:30 |
Discussant: Galen Toews, M.D. |
|
| 10:30-11:00 |
DISCUSSION |
|
| 11:00-11:15 |
BREAK |
|
|
|
|
|
| Factors involved in maturation of T
cells |
|
| 11:15-11:40 |
Speaker: Christopher Wilson, M.D. |
Regulation of Th1 Effector T Cell
Development
During
Ontogeny |
| 11:40-11:50 |
Discussant: Victoria Camerini, M.D. |
|
| 11:50-12:00 |
Discussant: F. Sessions Cole, M.D. |
|
| 12:00:12:30 |
DISCUSSION |
|
| 12:30-12:40 |
SESSION
SUMMARY |
|
|
|
| 12:40-1:30 |
LUNCH |
|
|
|
|
|
|
|
Session II - Pulmonary Immunity and
Inflammation:
A double-edged sword? |
Chair:
Allen Harmsen, Ph.D. |
|
|
| Regulation of the pulmonary immune
response |
|
| 1:30-1:55 |
Speaker: Mary Lipscomb, M.D. |
Antigen Handling and Processing in the Lung |
| 1:55-2:05 |
Discussant: Claire Doerschuk, M.D. |
|
| 2:05-2:15 |
Discussant: Robert North, Ph.D. |
|
| 2:15-2:45 |
DISCUSSION |
|
|
|
| Consequences of pulmonary immune
responses |
|
| 2:45-3:10 |
Speaker:Thomas Braciale, M.D., Ph.D. |
Lung
Damage During Immune Responses To
Infectious Diseases |
| 3:10-3:20 |
Discussant: Marsha Wills-Karp, Ph.D. |
|
| 3:20-3:30 |
Discussant:Arturo Casadevall, M.D.,
Ph.D. |
|
| 3:30-4:00 |
DISCUSSION |
|
| 4:00-4:15 |
BREAK |
|
|
|
| Role of various cell types and mediators as determinants
of pulmonary immune/inflammatory responses |
|
| 4:15-4:40 |
Speaker: Steven Kunkel, Ph.D. |
Mediators of Lung Immune Responses |
| 4:40-4:50 |
Discussant: Susan Swain, Ph.D. |
|
| 4:50-5:00 |
Discussant: Jeffery Curtis, M.D. |
|
| 5:00-5:30 |
DISCUSSION |
|
| 5:30-5:40 |
SESSION SUMMARY |
|
|
|
|
|
|
| August 27, 1999 |
|
|
|
|
|
|
|
| Session III - Inflammation as contributor to
pathogenesis in lung diseases |
Chair:
James Crapo, M.D. |
|
|
| Pulmonary inflammatory response and host defense
mechanisms |
|
|
8:30-8:55 |
Speaker: Jo Rae Wright, Ph.D. |
Unique Characteristics of Pulmonary Inflammation and Host Defense
Mechanisms |
|
8:55-9:05 |
Discussant: Galen Toews, M.D. |
|
|
9:05-9:15 |
Discussant: William Martin, M.D. |
|
|
9:15-9:45 |
DISCUSSION |
|
|
|
| Inflammation in pulmonary fibrosis, sarcoidosis, asthma,
COPD, and ARDS |
|
| 9:45-10:10 |
Speaker: Bruce Freeman, Ph.D. |
Oxidant/antioxidants in Mediating the Pulmonary
Immune Responses |
| 10:10-10:20 |
Discussant:Caroll Cross, M.D. |
|
| 10:20-10:30 |
Discussant: Stanley Hazen, M.D.,
Ph.D. |
|
| 10:30-11:00 |
DISCUSSION |
|
|
|
|
|
|
| 11:00-11:15 |
BREAK |
|
|
|
|
|
| Toward a new therapeutic approach |
|
|
11:15-11:40 |
Speaker: Thomas Martin, M.D. |
Early
Identification and Management of the Inflammatory Component of Pulmonary
Diseases |
|
11:40-12:00 |
Discussant: Gary Hunninghake, M.D. |
|
|
12:00-12:10 |
Discussant: David Schwartz, M.D. |
|
|
12:10:12:20 |
DISCUSSION |
|
|
|
|
|
|
| 12:20-12:40 |
SESSION
SUMMARY |
|
|
|
|
|
| Session IV - Summary Discussion, Recommendations, and
Prioritization |
Session Chairs
and Attendees |
|
|
|
|
12:40-2:00 |
DISCUSS AND LIST RECOMMENDATIONS IN PRIORITY
ORDER |
|
|
|
|
2:00 |
ADJOURN |
|
HOME
Department of Health
and Human Services
National
Institutes of Health
National Heart, Lung, and Blood
Institute